Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: The systematic investigation of gastrointestinal diseases in China (SILC)

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 2, 2011, Pages 133-141

  Zou, Duowu ^a   He, Jia ^b   Ma, Xiuqiang ^b   Chen, Jie ^a   Gong, Yanfang ^a   Man, Xiaohua ^a   Gao, Li ^a   Wang, Rui ^b   Zhao, Yanfang ^b   Yan, Xiaoyan ^b   Liu, Wenbin ^c   Wernersson, Börje ^d   Johansson, Saga ^d   Dent, John ^e   Sung, Joseph J ^f   Li, Zhaoshen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c ASTRAZENECA   (United Kingdom)

^d ASTRAZENECA R AND D   (Sweden)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

China; endoscopy; epidemiology; gastroesophageal reflux; peptic esophagitis

Indexed keywords

ARTICLE; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIGASTRIC BURNING; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOM SAMPLE; REFLUX DISEASE QUESTIONNAIRE; REFLUX ESOPHAGITIS; SYMPTOM;

ADOLESCENT; ADULT; AGED; CHINA; ENDOSCOPY; ESOPHAGITIS, PEPTIC; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; PEPTIC ULCER; PREVALENCE; QUESTIONNAIRES; REGURGITATION, GASTRIC; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 79951755505     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.521888     Document Type: Article

References (36)

1. Armstrong D. Systematic review: persistence and severity in gastroesophageal reflux disease. Aliment Pharmacol Ther 2008;28:841-53.
2. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) - a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
3. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-17. (Pubitemid 40559260)
4. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5: 17-26. (Pubitemid 46096825)
5. Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol 2007;5:4-16.
6. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barretts oesophagus in the general population: Loiano-Monghidoro study. Gut 2008; 57:1354-9.
7. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005;40: 275-85. (Pubitemid 40476458)
8. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barretts esophagus in the general population: an endoscopic study. Gastroenterology 2005;129:1825-31. (Pubitemid 41772961)
9. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31. (Pubitemid 29142625)
10. Wong BCY, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407.
11. Cao Y, Yan X, Ma X, Wang R, Fu Z, Johansson S, et al. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol 2008;8:37.
12. Yan X, Wang R, Zhao Y, Ma X, Fang J, Yan H, et al. Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol 2009;9:86.
13. Dent J, Vakil N, Jones R, Reimitz P, Schöning U, Halling K, et al. Validation of the reflux disease questionnaire for the diagnosis of gastroesophageal reflux disease in primary care. Gut 2007;56(Suppl 3):A75.
14. Veldhuyzen van Zanten S, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, et al. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks treatment with esomeprazole: a randomized, placebocontrolled study. Aliment Pharmacol Ther 2007;26:665-72. (Pubitemid 47246198)
15. Johnsson F, Hatlebakk J, Klintenberg AC, Román J. The symptom relieving effect of esomeprazole 40 mg daily in patients with heartburn. Gastroenterology 2001;120 (Suppl):A437.
16. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80. (Pubitemid 29333764)
17. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barretts esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392-9. (Pubitemid 44708937)
18. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol 2004;39:1280-8. (Pubitemid 39656845)
19. Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001;16:132-6. (Pubitemid 32226183)
20. Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005;40:1005-9. (Pubitemid 41291347)
21. Kim N, Lee SW, Cho SI, Park CG, Yang CH, Kim HS, et al. The prevalence and risk factors of erosive oesophagitis and non-erosive reflux disease: a nationwide multi-centre prospective study in Korea. Aliment Pharmacol Ther 2008;27 (2):173-85. (Pubitemid 350256608)
22. Lee SJ, Song CW, Jeen YT, Chun HJ, Lee HS,Um SH, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001;16:373-6. (Pubitemid 32397647)
23. Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997;92:668-71.
24. Tseng PH, Lee YC, Chiu HM, Huang SP, Liao WC, Chen CC, et al. Prevalence and clinical characteristics of Barretts esophagus in a Chinese general population. J Clin Gastroenterol 2008;42:1074-9.
25. Kim JH, Rhee P-L, Lee JH, Lee H, Choi YS, Son HJ, et al. Prevalence and risk factors of Barretts esophagus in Korea. J Gastroenterol Hepatol 2007;22:908-12. (Pubitemid 46911013)
26. Asling B, Jirholt J, Hammond P, Knutsson M, Walentinsson A, Davidson G, et al. Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia. Gut 2009;58:1063-9.
27. Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and nonerosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination.World J Gastroenterol 2007;13:6009-15. (Pubitemid 350238267)
28. Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumii K, et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2000;5: 24-9.
29. Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7. (Pubitemid 27181366)
30. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737.
31. Yagi S, Okada H, Takenaka R, Miyoshi M, Suzuki S, Toyokawa T, et al. Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients. Dis Esophagus 2009;22:361-7.
32. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005;100:1923-8.
33. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179:1523-30. (Pubitemid 29246603)
34. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897-907.
35. World Health Organization. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
36. China statistical yearbook: China Statistical Press. 2008. Available online at: indexeh.htm (accessed 15 July 2009).